Andréa C LeBlanc (Andrea C LeBlanc)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Top Venues

Nature communications

Cell death & disease

Acta neuropathologica communications

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Flores, Marie-Lyne Fillion, Andréa C LeBlanc
Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice. Cell death & disease 13 (10) (2022)
Joseph Flores, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, Andréa C LeBlanc
Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging. Nature communications 12 (1) (2021)
Anastasia Noël, Bénédicte Foveau, Andréa C LeBlanc
Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits. Cell death & disease 12 (3) (2021)
Joseph Flores, Anastasia Noël, Marie-Lyne Fillion, Andréa C LeBlanc
Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment. Cell death and differentiation (2021)
Joseph Flores, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, Andréa C LeBlanc
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging. Nature communications 11 (1) (2020)
Libin Zhou, Joseph Flores, Anastasia Noël, Olivier Beauchet, P Jesper Sjöström, Andréa C LeBlanc
Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice. Acta neuropathologica communications 7 (1) (2019)
Joseph Flores, Anastasia Noël, Bénédicte Foveau, Jeffrey Lynham, Clotilde Lecrux, Andréa C LeBlanc
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model. Nature communications 9 (1) (2018)